These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 7982310)
1. Management of thyroid papillary carcinoma with radioiodine in a patient with end stage renal disease on hemodialysis. Mello AM; Isaacs R; Petersen J; Kronenberger S; McDougall IR Clin Nucl Med; 1994 Sep; 19(9):776-81. PubMed ID: 7982310 [TBL] [Abstract][Full Text] [Related]
2. Radioiodine treatment of thyroid carcinoma in patients on maintenance hemodialysis. Daumerie C; Vynckier S; Caussin J; Jadoul M; Squifflet JP; de Patoul N; Wambersie A Thyroid; 1996 Aug; 6(4):301-4. PubMed ID: 8875750 [TBL] [Abstract][Full Text] [Related]
3. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin. Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210 [TBL] [Abstract][Full Text] [Related]
4. [Treatment with (131)I of thyroid remnants in a patient with papillary thyroid carcinoma and end-stage chronic renal failure]. Andres A; Tardín L; Santapau A; Razola P; Prats E; Parra A; Rivas MA; Ruiz P; Alvarez R; Camara A; Banzo J Rev Esp Med Nucl; 2010; 29(1):32-5. PubMed ID: 20018412 [TBL] [Abstract][Full Text] [Related]
5. The management of well-differentiated thyroid cancer with end-stage renal disease. Wang TH; Lee CH; Tseng LM; Liu RH Endocrine; 2003 Aug; 21(3):227-31. PubMed ID: 14515006 [TBL] [Abstract][Full Text] [Related]
6. Commentary: Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma. Terris DJ Head Neck; 2010 Jun; 32(6):698-9. PubMed ID: 20187017 [No Abstract] [Full Text] [Related]
7. The role of MR imaging in detecting nodal disease in thyroidectomy patients with rising thyroglobulin levels. Kaplan SL; Mandel SJ; Muller R; Baloch ZW; Thaler ER; Loevner LA AJNR Am J Neuroradiol; 2009 Mar; 30(3):608-12. PubMed ID: 19039052 [TBL] [Abstract][Full Text] [Related]
8. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196 [TBL] [Abstract][Full Text] [Related]
9. (131)I treatment in Differentiated Thyroid Cancer and End-Stage Renal Disease. Ortega AJ; Vázquez RG; Cuenca JI; Brocca MA; Castilla J; Martínez JM; González EN Rev Esp Med Nucl Imagen Mol; 2016; 35(1):29-33. PubMed ID: 26144699 [TBL] [Abstract][Full Text] [Related]
10. Disposition of radioiodine (131)I therapy for thyroid carcinoma in a patient with severely impaired renal function on chronic dialysis: a case report. Magné N; Magné J; Bracco J; Bussière F Jpn J Clin Oncol; 2002 Jun; 32(6):202-5. PubMed ID: 12110636 [TBL] [Abstract][Full Text] [Related]
11. Impact factors for the outcome of the first Shangguan L; Fang S; Zhang P; Han S; Shen X; Geng Y; Luo D; Zhao C Ann Nucl Med; 2019 Mar; 33(3):177-183. PubMed ID: 30515649 [TBL] [Abstract][Full Text] [Related]
12. [Optimization of 131I ablation in patients with differentiated thyroid carcinoma: comparison of early outcomes of treatment with 100 mCi versus 60 mCi]. Kukulska A; Krajewska J; Roskosz J; Handkiewicz-Junak D; Jarzab M; Paliczka E; Puch Z; Wygoda Z; Gubała E; Jarzab B Endokrynol Pol; 2006; 57(4):374-9. PubMed ID: 17006839 [TBL] [Abstract][Full Text] [Related]
13. Radiation dose assessment in radioiodine therapy. Dose-response relationships in differentiated thyroid carcinoma using quantitative scanning and PET. O'Connell ME; Flower MA; Hinton PJ; Harmer CL; McCready VR Radiother Oncol; 1993 Jul; 28(1):16-26. PubMed ID: 8234866 [TBL] [Abstract][Full Text] [Related]
14. Follow-up of differentiated thyroid cancer. Pacini F Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S492-6. PubMed ID: 12192551 [TBL] [Abstract][Full Text] [Related]
15. Iodine-131 treatment of thyroid papillary carcinoma in patients undergoing dialysis for chronic renal failure: a dosimetric method. Jiménez RG; Moreno AS; Gonzalez EN; Simón FJL ; Rodriguez JR; Jimenez JC; Córdoba MH; Albertino RV; Jimenez RA Thyroid; 2001 Nov; 11(11):1031-4. PubMed ID: 11762712 [TBL] [Abstract][Full Text] [Related]
16. Should 'low-risk' thyroid cancer patients with residual thyroglobulin be re-treated with iodine 131? Hindié E; Zanotti-Fregonara P; Duron F; Keller I; Bouchard P; Devaux JY Clin Endocrinol (Oxf); 2007 Mar; 66(3):329-34. PubMed ID: 17302864 [TBL] [Abstract][Full Text] [Related]